Biochemists Identify Another Piece of the Parkinson’s Disease Pathology Puzzle
An international team has discovered that the LRRK2 kinase regulates cellular trafficking by deactivating Rab proteins. This finding illuminates a novel route for therapeutic development and may accelerate testing of LRRK2 inhibitors as a disease-modifying therapy for Parkinson’s, the second most common neurodegenerative disease. An international public-private research consortium has identified and validated a cellular […]
The post Biochemists Identify Another Piece of the Parkinso
Read more »